Pilot study reveals altered joint range of motion and muscle function in Becker muscular dystrophy pigs, suggesting implications for therapeutic assessment.
Recently vertebrate animal models of Becker muscular dystrophy (BMD) have been developed. Here, we characterized the gait kinematics and muscle function of a naturally occurring BMD pig model of dystrophin insufficiency. BMD pigs tended to have alterations in joint range of motion (ROM): hip (67%, 95% CI -0.64 to 14.12 degrees), knee (8%, 95% CI -17.14 to 12.13 degrees) and ankle (11%, 95% CI -15 to 8.46 degrees) ROM. While parameters were unaltered in extensor muscles, the dystrophin levels in flexor tibiotarsal joint muscles correlated with fatigue index in BMD pigs. As well as reduced isometric force (48%, 95% CI -1.86 to -0.61 N-m), and a 33% increase in fatigue index (95% CI -36.25 to 96.71 percent); the extensor muscles had no observable reductions in muscle force, with a 48% increase in fatigue index (95% CI -232.6 to 472.6 percent). Histological analysis of muscle biopsies further supported a BMD phenotype in the flexor muscles of BMD pigs, with a 75% (95% CI -55.14 to -15.66 percent) decrease in large and a 43% (95% CI 17.74 to 57.38 percent) increase in small muscle fiber cross-sectional area. Dystrophin protein abundance was 34% less in flexor muscles from BMD pigs (95% CI -87.9 to 20.2 percent healthy) with a 2.5-fold increase in creatine kinase (CK) levels (95% CI -214 to 1973 pg/dL), and no other abnormalities evident in the blood chemistry profile. Taken together, our model may serve as a clinically relevant model of BMD to assess safety and efficacy of therapeutics.
No takes yet. Share an insight, caveat, or question.
Morton et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: